744 related articles for article (PubMed ID: 12500196)
1. Low-dose TNF-alpha protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning.
Teoh N; Leclercq I; Pena AD; Farrell G
Hepatology; 2003 Jan; 37(1):118-28. PubMed ID: 12500196
[TBL] [Abstract][Full Text] [Related]
2. Hepatic ischemic preconditioning in mice is associated with activation of NF-kappaB, p38 kinase, and cell cycle entry.
Teoh N; Dela Pena A; Farrell G
Hepatology; 2002 Jul; 36(1):94-102. PubMed ID: 12085353
[TBL] [Abstract][Full Text] [Related]
3. Dual role of tumor necrosis factor-alpha in hepatic ischemia-reperfusion injury: studies in tumor necrosis factor-alpha gene knockout mice.
Teoh N; Field J; Sutton J; Farrell G
Hepatology; 2004 Feb; 39(2):412-21. PubMed ID: 14767994
[TBL] [Abstract][Full Text] [Related]
4. Delayed ischemic preconditioning protects against liver ischemia-reperfusion injury in vivo.
Romanque P; Díaz A; Tapia G; Uribe-Echevarría S; Videla LA; Fernandez V
Transplant Proc; 2010 Jun; 42(5):1569-75. PubMed ID: 20620476
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 is a key mediator of the hepatoprotective and pro-proliferative effects of ischaemic preconditioning in mice.
Teoh N; Field J; Farrell G
J Hepatol; 2006 Jul; 45(1):20-7. PubMed ID: 16600417
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 and STAT3 protect the liver from hepatic ischemia and reperfusion injury during ischemic preconditioning.
Matsumoto T; O'Malley K; Efron PA; Burger C; McAuliffe PF; Scumpia PO; Uchida T; Tschoeke SK; Fujita S; Moldawer LL; Hemming AW; Foley DP
Surgery; 2006 Nov; 140(5):793-802. PubMed ID: 17084723
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning.
Dawn B; Guo Y; Rezazadeh A; Wang OL; Stein AB; Hunt G; Varma J; Xuan YT; Wu WJ; Tan W; Zhu X; Bolli R
J Mol Cell Cardiol; 2004 Jul; 37(1):51-61. PubMed ID: 15242735
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte NF-kappaB activation is hepatoprotective during ischemia-reperfusion injury and is augmented by ischemic hypothermia.
Kuboki S; Okaya T; Schuster R; Blanchard J; Denenberg A; Wong HR; Lentsch AB
Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G201-7. PubMed ID: 16950761
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of liver ischemic preconditioning on liver and lung injury induced by hepatic ischemia-reperfusion in the rat.
Peralta C; Prats N; Xaus C; Gelpí E; Roselló-Catafau J
Hepatology; 1999 Dec; 30(6):1481-9. PubMed ID: 10573528
[TBL] [Abstract][Full Text] [Related]
10. Effects of ischemic preconditioning on regenerative capacity of hepatocyte in the ischemically damaged rat livers.
Bedirli A; Kerem M; Pasaoglu H; Erdem O; Ofluoglu E; Sakrak O
J Surg Res; 2005 May; 125(1):42-8. PubMed ID: 15836849
[TBL] [Abstract][Full Text] [Related]
11. Endogenous danger signals trigger hepatic ischemia/reperfusion injury through toll-like receptor 4/nuclear factor-kappa B pathway.
Wang H; Li ZY; Wu HS; Wang Y; Jiang CF; Zheng QC; Zhang JX
Chin Med J (Engl); 2007 Mar; 120(6):509-14. PubMed ID: 17439747
[TBL] [Abstract][Full Text] [Related]
12. Ryanodine receptor antagonism protects the ischemic liver and modulates TNF-alpha and IL-10.
López-Neblina F; Toledo-Pereyra LH; Toledo AH; Walsh J
J Surg Res; 2007 Jun; 140(1):121-8. PubMed ID: 17359999
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 18 causes hepatic ischemia/reperfusion injury by suppressing anti-inflammatory cytokine expression in mice.
Takeuchi D; Yoshidome H; Kato A; Ito H; Kimura F; Shimizu H; Ohtsuka M; Morita Y; Miyazaki M
Hepatology; 2004 Mar; 39(3):699-710. PubMed ID: 14999688
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent.
Camargo CA; Madden JF; Gao W; Selvan RS; Clavien PA
Hepatology; 1997 Dec; 26(6):1513-20. PubMed ID: 9397992
[TBL] [Abstract][Full Text] [Related]
15. Preconditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factor-induced P-selectin up-regulation in the rat.
Peralta C; Fernández L; Panés J; Prats N; Sans M; Piqué JM; Gelpí E; Roselló-Catafau J
Hepatology; 2001 Jan; 33(1):100-13. PubMed ID: 11124826
[TBL] [Abstract][Full Text] [Related]
16. Impaired hepatic regeneration by ischemic preconditioning in a rat model of small-for-size liver transplantation.
Yao A; Li X; Pu L; Zhong J; Liu X; Yu Y; Zhang F; Kong L; Sun B; Wang X
Transpl Immunol; 2007 Jul; 18(1):37-43. PubMed ID: 17584601
[TBL] [Abstract][Full Text] [Related]
17. Hydrodynamics-based transfection of plasmid encoding receptor activator for nuclear factor kappa B-Fc protects against hepatic ischemia/reperfusion injury in mice.
Shi J; Shao W; Yang D; Zhao L; Deng L; Wang X; Sun B
Liver Transpl; 2010 May; 16(5):611-20. PubMed ID: 20440770
[TBL] [Abstract][Full Text] [Related]
18. Anti-ischemic effect of selectin blocker through modulation of tumor necrosis factor-alpha and interleukin-10.
López-Neblina F; Toledo-Pereyra LH
J Surg Res; 2007 Apr; 138(2):275-83. PubMed ID: 17254609
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of crosstalk between TNF-induced NF-kappaB and JNK activation in hepatocytes.
Wullaert A; Heyninck K; Beyaert R
Biochem Pharmacol; 2006 Oct; 72(9):1090-101. PubMed ID: 16934229
[TBL] [Abstract][Full Text] [Related]
20. Ischemic preconditioning and intermittent clamping improve murine hepatic microcirculation and Kupffer cell function after ischemic injury.
Vajdová K; Heinrich S; Tian Y; Graf R; Clavien PA
Liver Transpl; 2004 Apr; 10(4):520-8. PubMed ID: 15048795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
